DB06439ApprovedInvestigationalSmall molecule
Tyloxapol is a non-ionic detergent often used as a surfactant.
- Mechanism
- Curator reviewed
Tyloxapol, when injected IP, blocks plasma lipolytic activity, and thus the breakdown of triglyceride-rich lipoproteins. It has also been shown to be inhibitor of lipoprotein lipase, thus preventing triglyceride uptake.
- Primary indication
- Tyloxapol is an inhaled surfactant that assists in removing and liquefying and removing bronchopulmonary secretions with mucus and pus.Curator reviewed
Resolves to
Clinical / RWD
What you can answer from here — as of March 03, 2026
6Protein targetsEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with Tyloxapol, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account